UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031780
Receipt number R000036279
Scientific Title Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study)
Date of disclosure of the study information 2018/03/21
Last modified on 2020/03/25 09:34:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study)

Acronym

Extensive Peritoneal Lavage for Gastric Cancer (P3)

Scientific Title

Extensive Peritoneal Lavage after Curative Gastrectomy for Gastric Cancer: a Randomized Controlled Trial (EXPEL Study)

Scientific Title:Acronym

Extensive Peritoneal Lavage for Gastric Cancer (P3)

Region

Japan Asia(except Japan)


Condition

Condition

Gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study is carried out to determine the merit and reliability of extensive intraoperative peritoneal lavage as a preventive strategy
Hypothesis: EPL significantly improve the overall survival of patients by reducing the risk of peritoneal recurrence

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase III


Assessment

Primary outcomes

Overall survival

Key secondary outcomes

Disease free survival
Peritoneal recurrence rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Study arm: Extensive peritoneal lavage. The peritoneal cavity will be washed with 10 liters of normal saline (1 liter each cycle for 10 cycles).

Interventions/Control_2

Control arm: Standard treatment. The peritoneal cavity will be washed within 2 liters of normal saline.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

21 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Patients who have T3 (subserosal) or T4 (serosal) disease based on CT scan and intra-operative inspection with any N staging and M0 gastric cancer.
2.Patients planned for open or laparoscopic gastrectomy.
3.Patients undergoing gastrectomy with curative intent.
4.Lower age limit of research subjects 21 years old and upper age limit of 80 years old.
5.Ability to provide informed consent
6.Ability to come back for study visits throughout the 3 years duration after surgery
7.Patients are local residents

Key exclusion criteria

1.Patients who undergo a palliative gastrectomy.
2.Patients who undergo a gastrectomy as emergency.
3.Vulnerable persons under age of 21.
4.Patients receiving neoadjuvant therapy.
5.Patients presented with life-threatening bleeding from tumour
6.ASA score of 4 & 5
7.Patients with another primary cancer within last 5 years
8.Patients with gross peritoneal and liver metastasis at surgery.

Target sample size

800


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Prof. Jimmy So

Organization

National University Hospital, Singapore

Division name

Department of Surgery

Zip code


Address

National University Hospital Singapore Pte Ltd, 5 Lower Kent Ridge Road, Singapore 119074

TEL

+65-6772-3191

Email

sursbyj@nus.edu.sg


Public contact

Name of contact person

1st name
Middle name
Last name Prof. Jimmy So

Organization

National University Hospital, Singapore

Division name

Department of Surgery

Zip code


Address

National University Hospital Singapore Pte Ltd, 5 Lower Kent Ridge Road, Singapore 119074

TEL

+65-6772-3191

Homepage URL

https://clinicaltrials.gov/ct2/show/study/NCT02140034?term=NCT%3A02140034&rank=1&view=record

Email

sursbyj@nus.edu.sg


Sponsor or person

Institute

National University Hospital, Singapore

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

NCT:02140034

Org. issuing International ID_1

Clinical Trial.gov

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター東病院(千葉県)、福島県立医科大学(福島県)、岐阜大学附属病院(岐阜県)、静岡県立静岡がんセンター(静岡県)、愛知県がんセンター(愛知県)、新潟県立新潟がんセンター(新潟県)、神奈川県立がんセンター(神奈川県)、国立シンガポール大学(シンガポール)、Tan Tock Seng病院(シンガポール)、Ajou大学(韓国)、Yonsei大学(韓国)、Peking大学(中国)、Seoul National大学(韓国)、Seoul National大学Bundang病院(韓国)、National cancer center(韓国)、国立マレーシア大学(マレーシア)、Queen mary病院(香港)、Southern medical大学Nanfang病院(中国)、the Chinese University of Hong Kong Prince of Wales病院(香港)、Seoul St. Mary's病院(韓国)


Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 05 Month 16 Day

Date of IRB

2018 Year 03 Month 08 Day

Anticipated trial start date

2018 Year 03 Month 08 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 18 Day

Last modified on

2020 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036279


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name